Sternocostoclavicular Hyperostosis

A rare, benign rheumatologic disorder or syndrome characterized by hyperostosis and soft tissue ossification between the clavicles and the anterior part of the upper ribs. It is often associated with the dermatologic disorder palmoplantar pustulosis, particularly in Japan. Careful diagnosis is required to distinguish it from psoriatic arthritis, OSTEITIS DEFORMANS, and other diseases. Spondylitis of pustulosis palmaris et plantaris is one of the possible causes; also, evidence suggests one origin may be bone infection. Bone imaging is especially useful for diagnosis. It was originally described by Sonozaki in 1974.
Also Known As:
Hyperostosis, Sternocostoclavicular; Hyperostoses, Sternocostoclavicular; Sternocostoclavicular Hyperostoses
Networked: 9 relevant articles (3 outcomes, 0 trials/studies) for this Disease, Comments

Relationship Network

Disease Context: Research Results

Related Diseases

1. Pain (Aches)
2. Osteoporosis
3. Hyperostosis
4. Osteomyelitis
5. Focal Infection


1. Ringe, J D: 1 article (09/2007)
2. Body, J-J: 1 article (09/2007)
3. Ringe, Johann D: 1 article (01/2006)
4. Farahmand, Parvis: 1 article (01/2006)
5. Faber, Herbert: 1 article (01/2006)
6. Wolf, Gerald: 1 article (05/2002)
7. Schwarz, Thomas: 1 article (05/2002)
8. Lorbach, Mark Peter: 1 article (05/2002)
9. Aigner, Reingard Maria: 1 article (05/2002)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Sternocostoclavicular Hyperostosis:
1. ibandronic acid (Boniva)FDA Link
2. Anti-Bacterial Agents (Antibiotics)IBA
3. Chronic recurrent multifocal osteomyelitisIBA
4. HLA-B27 Antigen (HLA B27 Antigen)IBA
5. Technetium Tc 99m MedronateIBA

Therapies and Procedures

1. Aftercare (After-Treatment)

blog comments powered by Disqus
for Sternocostoclavicular Hyperostosis,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 3 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$24.95 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$490.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>